ClinicalTrials.Veeva

Menu

Salutogenic Frailty Prevention Program for Women Aged 55 Years and Over (SAFRAPP)

I

Istanbul University - Cerrahpasa (IUC)

Status

Unknown

Conditions

Frailty Syndrome
Frailty
Sense of Coherence
Salutogenesis

Treatments

Behavioral: Salutogenic Frailty Prevention Program

Study type

Interventional

Funder types

Other

Identifiers

NCT04787432
IU-Cerrahpasa

Details and patient eligibility

About

Frailty is a condition of reduced the capacity in multiple body systems and causing adverse outcomes because of decreasing the ability to cope with stressors. Female sex, the changes of the body imposed by ageing, and coping strategies for stressors are causal mechanisms in the development of frailty. This project is designed with the salutogenic model that is focused on the concepts of health, stress, and coping. The aim of this project is to assess the effect of Salutogenic Frailty Prevention Program on promoting sense of coherence and preventing the development of frailty in women aged 55 years and over

Enrollment

84 estimated patients

Sex

Female

Ages

55+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Willing to participate in the study
  • Woman aged 55 years and over
  • Pre-frail (Total FRAIL scale score 1 or 2)
  • Has Internet access

Exclusion criteria

  • To be semi-dependent and dependent according to the Katz Daily Activities Activity Scale
  • To have any cognitive, psychiatric and neurological disorders
  • To have any surgical operation in the past 3 month
  • Communication barrier (due to hearing/vision impairment)

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

84 participants in 2 patient groups

Intervention
Experimental group
Description:
Experimental: SAFRAPP Intervention Participants in this group will receive a 6-week SAFRAPP intervention, comprising of laughter yoga, health education and case management. SAFRAPP will be conducted on social media (Facebook and WhatsApp).
Treatment:
Behavioral: Salutogenic Frailty Prevention Program
Control Grup
No Intervention group
Description:
The control group will not receive any intervention during the study. Participants in the control group will take the same program after the study is completed.

Trial contacts and locations

0

Loading...

Central trial contact

Merve ALTINER YAS, MSc; Selda SECGINLI, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems